Kenneth T. Mills, Director at REGENXBIO Inc. (RGNX), sold 55,180 shares at $13.78 ($766K) on 2024-07-24, disclosed to the SEC on 2024-07-26.
Scheduled sale ($766k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.78 | 12,221 | $168K | 22.0% |
| 2 | $13.78 | 12,221 | $168K | 22.0% |
| 3 | $13.96 | 15,369 | $215K | 28.0% |
| 4 | $13.96 | 15,369 | $215K | 28.0% |
| Total | $13.88 avg | 55,180 | $766K | 100% |
| Filing → |
| RGNX | SELL | 2024-05-16 | $237K | — | Filing → |
| RGNX | SELL | 2024-04-17 | $273K | — | Filing → |
| RGNX | SELL | 2024-03-18 | $328K | — | Filing → |